Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
about
How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysisRecommended patient-reported core set of symptoms to measure in adult cancer treatment trialsA systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting.Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial.Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study.Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: design and evaluation.The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.A randomized trial of weekly symptom telemonitoring in advanced lung cancerTechnology and quality of life outcomesManagement of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.Validation study of a web-based assessment of functional recovery after radical prostatectomyDevelopment of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).Communication about symptoms and quality of life issues in patients with cancer: provider perceptionsElectronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC.Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff.Commentary: encouraging clinicians to incorporate longitudinal patient-reported symptoms in routine clinical practiceThe Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoringStrategies to use tablet computers for collection of electronic patient-reported outcomes.The role of informatics in promoting patient-centered care.Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia.How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy.Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response.Probing the benefits of real-time tracking during cancer care.Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.Reliability of adverse symptom event reporting by clinicians.Development and implementation of a clinician reporting system for advanced stage cancer: initial lessons learned.Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapyLongitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.TRANSFoRm eHealth solution for quality of life monitoring.Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time?Quality of life during chemotherapy in lung cancer patients: results across different treatment linesAdverse symptom event reporting by patients vs clinicians: relationships with clinical outcomesAutomated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCTExploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
P2860
Q28070314-FA6F55A7-1F1A-4838-A25C-74CCD4C52645Q28655361-CA4AB3B9-47DE-4B14-A660-48A495ACA518Q30541146-1293A8DE-940E-4CDD-8D6D-71C2FC9758FBQ30565997-58C395CD-EE1B-4577-89CF-B9C09265BFF0Q30620556-417052C0-35F2-45E4-AF33-02EF973E5873Q30826661-89F405D6-2392-4698-8239-C30106C01B6DQ33448451-4066EF79-261F-4192-A79B-30D2D1AB1D5AQ33573092-41B094D1-81AB-4668-AA62-10283D6B713DQ33579085-E290DC69-AA98-4A8C-97BA-003FB6495AECQ33784214-8F861A4D-F543-461B-BE61-19E16D020099Q33854239-8BEF7225-2681-4216-BA71-DADBD52F2210Q34081632-2EB395F1-E7A7-471E-88EC-979130BB2B7DQ34354355-EDAAE28C-E271-48A2-BC38-D68D0E2962DDQ34389460-769D0DF9-A236-4F3A-86C6-99F6F1ACC563Q34420379-D8422467-BBDC-4667-994E-1FDBE37B10CCQ34454835-A427A8FD-EB10-434B-BD52-B72F8AE7B4A3Q34459694-CBAE6C4E-A5F3-4035-9849-0BC8D69EB550Q34472415-C8AAF5F2-65A0-4878-88A9-BAC354AB705CQ35030305-8A82DB1F-2020-4AD4-BAF0-7E99CD5699E9Q35137693-A8056BDD-F150-47FB-8AB2-F557186299CDQ35184927-75FAEF92-F079-4712-BAAC-8CE07F70E94DQ35914925-A07561AD-7E0B-43A2-AF36-2100362414ABQ36052922-43473278-4D0D-47C9-8454-C4AD68826BD8Q36058491-BB78272B-CB4B-4BCA-AE12-95B573875159Q36519214-14659F34-1D2F-436E-8137-C20EAD2572E5Q36761902-1B5C026A-9291-4833-A4FE-CEF18F88B5C6Q36787723-83830082-2E9B-4DA0-ADF8-A4FDAFA2AB8FQ36858973-C9E33A18-7A07-4F2A-8E29-9FC7B9CD3C65Q36914459-2D1B4F04-76B9-4B42-8293-99ACDA672312Q36927640-43094896-4E3B-41D9-BD2F-E708A46A9FBFQ36941450-6F58B66C-DE48-415C-A60F-7891E7EC19F3Q36977042-46E26E40-C333-4E02-8EE4-DC146A11C52DQ37011791-E6B76C8F-E087-4610-9CD2-EAD0651ED04FQ37130352-2F6B11E3-8E81-40D7-BF58-D6644A128F6DQ37211259-BE708F0B-ED96-420E-8853-8E254AF844EBQ37213465-FACECC24-7C37-4A90-BA42-A83819C3F397Q37279248-6A4B6BB9-158F-432C-BDE5-BE7EB9BF04D0Q37452740-B52D79F2-5E0E-4307-AB74-D3248AA3D6D8Q37693325-515D4675-5B7F-4235-8434-DA31FD243129Q37706400-0DD418AF-31B2-4098-A381-F438E4DACC93
P2860
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@en
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@nl
type
label
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@en
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@nl
prefLabel
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@en
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@nl
P2093
P356
P1476
Long-term toxicity monitoring ...... tients receiving chemotherapy.
@en
P2093
Alexia Iasonos
Allison Barz
Ann Culkin
David Artz
Deborah Schrag
Howard I Scher
John Speakman
Mary McCabe
Paul Fearn
Rena Farquhar
P304
P356
10.1200/JCO.2007.11.2243
P407
P577
2007-12-01T00:00:00Z